Inteligex
Inteligex is a company developing proprietary stem cell-based therapeutics to restore function in individuals with spinal cord injury (SCI) and other diseases of the Central Nervous System (CNS). Their regenerative stem cell therapies address acute and chronic SCI, building on over 20 years of research. Inteligex aims to be the first company to market with an effective treatment for SCI, positioning itself as a leader in personalized regenerative medicine. Their platform is also being optimized for conditions such as cerebral palsy, stroke, multiple sclerosis, and amyotrophic lateral sclerosis. The company utilizes AI solutions for disease progression prediction and biomaterial strategies to offer a personalized treatment approach. Inteligex's mission is to facilitate meaningful functional recovery, promote patient independence, and improve quality of life, while also reducing healthcare costs and capturing a significant share of the multi-billion dollar SCI market.
Inteligex
Inteligex is a company developing proprietary stem cell-based therapeutics to restore function in individuals with spinal cord injury (SCI) and other diseases of the Central Nervous System (CNS). Their regenerative stem cell therapies address acute and chronic SCI, building on over 20 years of research. Inteligex aims to be the first company to market with an effective treatment for SCI, positioning itself as a leader in personalized regenerative medicine. Their platform is also being optimized for conditions such as cerebral palsy, stroke, multiple sclerosis, and amyotrophic lateral sclerosis. The company utilizes AI solutions for disease progression prediction and biomaterial strategies to offer a personalized treatment approach. Inteligex's mission is to facilitate meaningful functional recovery, promote patient independence, and improve quality of life, while also reducing healthcare costs and capturing a significant share of the multi-billion dollar SCI market.